Pyoderma gangrenosum in association with Janus kinase 2 (JAK2V617F) mutation

被引：27
作者：
Palanivel, J. A. [1 ]
Macbeth, A. E. [1 ]
Levell, N. J. [1 ]
机构：
[1] Norfolk & Norwich Univ Hosp & NHS Trust, Dept Dermatol, Norwich, Norfolk, England
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2013年 / 38卷 / 01期
关键词：
PATHWAY;
D O I：
10.1111/j.1365-2230.2012.04375.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Pyoderma gangrenosum (PG) commonly occurs in association with various haematological and inflammatory disorders. We report a new association, a Janus kinase (JAK)2 mutation, in a 63-year-old patient with PG. We hypothesise that PG occurs by direct activation of JAK along with signal transducers and activators of transcription (STAT), a common mechanism involved in the pathogenesis of inflammatory and haematological diseases.
引用
收藏
页码：44 / 46
页数：3
相关论文
共 7 条
  • [1] Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population
    Ferguson, Lynnette R.
    Han, Dug Yeo
    Fraser, Alan G.
    Huebner, Claudia
    Lam, Wen Jiun
    Morgan, Angharad R.
    Duan, He
    Karunasinghe, Nishi
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 690 (1-2) : 108 - 115
  • [2] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
    Levine, RL
    Wadleigh, M
    Cools, J
    Ebert, BL
    Wernig, G
    Huntly, BJP
    Boggon, TJ
    Wlodarska, L
    Clark, JJ
    Moore, S
    Adelsperger, J
    Koo, S
    Lee, JC
    Gabriel, S
    Mercher, T
    D'Andrea, A
    Fröhling, S
    Döhner, K
    Marynen, P
    Vandenberghe, P
    Mesa, RA
    Tefferi, A
    Griffin, JD
    Eck, MJ
    Sellers, WR
    Meyerson, M
    Golub, TR
    Lee, SJ
    Gilliland, DG
    [J]. CANCER CELL, 2005, 7 (04) : 387 - 397
  • [3] Targeting myeloproliferative neoplasms with JAK inhibitors
    Pardanani, Animesh
    Tefferi, Ayalew
    [J]. CURRENT OPINION IN HEMATOLOGY, 2011, 18 (02) : 105 - 110
  • [4] The JAK/STAT signaling pathway
    Rawlings, JS
    Rosler, KM
    Harrison, DA
    [J]. JOURNAL OF CELL SCIENCE, 2004, 117 (08) : 1281 - 1283
  • [5] ROSS HJ, 1991, CANCER, V68, P441, DOI 10.1002/1097-0142(19910715)68:2<441::AID-CNCR2820680239>3.0.CO
  • [6] 2-4
  • [7] Walker JG, 2005, J RHEUMATOL, V32, P1650
1